Replikins explains how an analysis of gene structures in the dengue virus led to the development of a vaccine candidate

How a Genetic Analysis of Dengue Led to the Vaccine Candidate

Replikins explains how an analysis of gene structures in the dengue virus led to the development of a vaccine candidate Replikins Ltd, the company that first identified a group of peptides called Replikins, has announced that one of its studies on the genetic structure of the dengue virus has been instrumental in the development of their synthetic dengue vaccine candidate. …

Sanofi’s Dengue Vaccine Produces Moderate results

¬† The New Dengue Vaccine From Sanofi Shows Promise The virus spread through the day biting Aedes mosquitoes, affects more than one million people a year, threatening about 40% of the worlds population. Sanofi’s candidate vaccine will protect children already infected with the mosquito-borne dengue fever, from a potentially fatal hemorrhagic fever.¬†Evidence suggest that the new dengue fever vaccine protects …